James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 50,000 shares at $64.98 ($3.2M) on 2018-10-08, disclosed to the SEC on 2018-10-10.
Open-market sale of $3.2M GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.98 | 16,215 | $1.1M | 32.5% |
| 2 | $65.82 | 6,310 | $415K | 12.8% |
| 3 | $66.52 | 2,475 | $165K | 5.1% |
| 4 | $64.23 | 19,270 | $1.2M | 38.2% |
| 5 | $64.86 | 5,730 | $372K | 11.5% |
| Total | $64.86 avg | 50,000 |
| $3.2M |
| 100% |
| Filing → |
| GHDX | SELL | 2019-06-10 | $459K | — | Filing → |
| GHDX | SELL | 2019-05-10 | $421K | — | Filing → |
| GHDX | SELL | 2018-06-06 | $4.3M | — | Filing → |